gMG clinical trials at UCSF
1 research study open to eligible people
gMG is generalized myasthenia gravis, a condition that causes muscle weakness. UCSF is running a study testing an IV medicine in children with gMG and measuring blood levels, safety, and immune response. The study also records how symptoms change over time and reports side effects.
Showing trials for
Pharmacodynamics, Efficacy, Safety, and Immunogenicity of Ravulizumab Administered Intravenously in Pediatric Participants With Generalized Myasthenia Gravis (gMG)
open to all eligible people
The primary purpose of this study is to characterize the pharmacokinetics and pharmacodynamics of treatment with ravulizumab intravenous infusion in pediatric participants with gMG.
San Francisco, California and other locations
Our lead scientists for gMG research studies include Jonathan Strober.
Last updated: